Clinical trial
The Medtronic TAVR 2.0 US Clinical Study
NCT02738853 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Medtronic TAVR 2.0 US Clinical Study
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- December 15, 2021
- Enrollment
- 93 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.